Literature DB >> 24202696

Fatal metformin overdose: case report and postmortem biochemistry contribution.

Alessandro Bonsignore1, Fulvia Pozzi, Giulio Fraternali Orcioni, Francesco Ventura, Cristian Palmiere.   

Abstract

Metformin is an oral antihyperglycemic agent used in the management of type 2 diabetes mellitus. Lactic acidosis from metformin overdose is a rare complication of metformin therapy and occurs infrequently with therapeutic use. Fatal cases, both accidental and intentional, are extremely rare in clinical practice. Metformin is eliminated by the kidneys, and impaired renal function can result in an increased plasma concentration of the drug. In this report, we describe an autopsy case involving a 70-year-old woman suffering from diabetes mellitus and impaired renal function who received metformin treatment. Metformin concentrations in the peripheral blood collected during hospitalization and femoral blood collected during autopsy were 42 and 47.3 µg/ml, respectively. Lactic acidosis (29.10 mmol/l) was objectified during hospitalization. Furthermore, postmortem biochemistry allowed ketoacidosis to be diagnosed (blood β-hydroxybutyrate, 10,500 µmol/l). Death was attributed to lactic acidosis due to metformin intoxication. Increased plasma concentrations of the drug were attributed to severely impaired renal function. The case emphasizes the usefulness of performing exhaustive toxicology and postmortem biochemistry towards the more complete understanding of the pathophysiological mechanisms that may be involved in the death process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24202696     DOI: 10.1007/s00414-013-0927-3

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  39 in total

1.  Analysis of metformin in antemortem serum and postmortem specimens by a novel HPLC method and application to an intoxication case.

Authors:  Karla A Moore; Barry Levine; Jack M Titus; David R Fowler
Journal:  J Anal Toxicol       Date:  2003 Nov-Dec       Impact factor: 3.367

2.  Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin.

Authors:  Dean T Eurich; Sumit R Majumdar; Finlay A McAlister; Ross T Tsuyuki; Jeffrey A Johnson
Journal:  Arch Intern Med       Date:  2011-06-13

3.  2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.

Authors:  Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Barry H Rumack; Richard C Dart
Journal:  Clin Toxicol (Phila)       Date:  2012-12       Impact factor: 4.467

4.  Lactic acidosis in patients with diabetes.

Authors:  Janusz Krzymień; Waldemar Karnafel
Journal:  Pol Arch Med Wewn       Date:  2013-01-08

5.  The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.

Authors:  Janna K Duong; Timothy J Furlong; Darren M Roberts; Garry G Graham; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

6.  Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs.

Authors:  S A Al-Abri; S Hayashi; K L Thoren; K R Olson
Journal:  Clin Toxicol (Phila)       Date:  2013-04-01       Impact factor: 4.467

7.  2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report.

Authors:  Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Jody L Green; Barry H Rumack; Sandra L Giffin
Journal:  Clin Toxicol (Phila)       Date:  2010-12       Impact factor: 4.467

8.  Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients.

Authors:  M Kosmalski; A Drozdowska; A Sliwinska; J Drzewoski
Journal:  Adv Med Sci       Date:  2012-06-01       Impact factor: 3.287

9.  [Overdose of metformin secondary to acute renal insufficiency: a report of six cases].

Authors:  J Ortega Carnicer; A Ambrós Checa; C Martín Rodríguez; F Ruiz Lorenzo; M Portilla Botelho; L Gómez Grande
Journal:  Med Intensiva       Date:  2007-12       Impact factor: 2.491

10.  Fatal metformin overdose presenting with progressive hyperglycemia.

Authors:  Jeffrey R Suchard; Thomas A Grotsky
Journal:  West J Emerg Med       Date:  2008-08
View more
  5 in total

1.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

Review 2.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

3.  Post-mortem analysis of lactate concentration in diabetics and metformin poisonings.

Authors:  T Keltanen; T Nenonen; R A Ketola; I Ojanperä; A Sajantila; K Lindroos
Journal:  Int J Legal Med       Date:  2015-09-01       Impact factor: 2.686

4.  Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO.

Authors:  Crystal Ives Tallman; Yu Zhang; Nicholas Black; Kara Lynch; Mohamed Fayed; Patil Armenian
Journal:  Toxicol Rep       Date:  2021-12-21

5.  Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.

Authors:  Verena Schwetz; Florian Eisner; Gernot Schilcher; Kathrin Eller; Johannes Plank; Alice Lind; Thomas R Pieber; Julia K Mader; Philipp Eller
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.